How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93%

Shares of Black Diamond (BDTX) have gained 20.5% over the past four weeks to close the last trading session at $5.41, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$10.60 indicates a potential upside of 95.9%.The mean estimate comprises five short-term price targets with a standard deviation of $0.89. While the lowest estimate of$10 indicates an 84.8% increase from the curren ...